Cancer Cell International · 2021 · 22 citations · 16 references
MedicineMolecular BiologyOncologyCarcinogenesisDna RepairMolecular OncologyApoptosis In CancerDna Damage SignalingDna Repair In CarcinogenesisMalignant NeoplasmsOncogenic Signaling PathwaysPancreatic CancerCancer Cell ApoptosisCell Cycle Arrest MechanismsCell Cycle Checkpoint DisruptionCell Cycle Checkpoint PerturbationCell Cycle InhibitionDna Damage Checkpoint SignalingDna Damage InductionTumor Metabolism
BACKGROUND: ALDOA is a glycolytic enzyme found mainly in developing embryos, adult muscle and various malignant tumours, including pancreatic tumours. Our previous study revealed that ALDOA, an oncogene, can promote the proliferation and metastasis of pancreatic tumours. Furthermore, ALDOA could predict poor prognosis in patients with pancreatic tumours. METHODS: IHC analysis of PDAC tissues was conducted. Western blotting, PCR, cellular IF experiments and cell cycle assessment were conducted utilizing cell lines. GSEA and KEGG pathway analysis were used to identify potential downstream pathways. RESULTS: To explore the effects of ALDOA on the occurrence and development of pancreatic tumours, we analysed the RNA sequencing results and found that ALDOA could inhibit the DDR. Under normal circumstances, when DNA is damaged, initiation of the DDR causes cell cycle arrest, DNA repair or cell apoptosis. Further experiments showed that ALDOA could inhibit DNA repair and reverse cell cycle arrest induced by DNA damage so that DNA damage persisted to promote the occurrence and progression of cancer. CONCLUSIONS: Regarding the molecular mechanism, we found that ALDOA inhibited the DDR and improved activation of the cell cycle checkpoint PLK1 by suppressing ATM, which promotes tumour cell progression. Consequently, ALDOA has a profound effect on pancreatic cancer development.
16
Polo-like kinase-1 is a target of the DNA damage checkpoint
Veronique A. J. Smits, Rob Klompmaker, Lionel Arnaud et al. · Nature Cell Biology · 2000 · 436 citations
ALDOA functions as an oncogene in the highly metastatic pancreatic cancer
Shunrong Ji, Bo Zhang, Jiang Liu et al. · Cancer Letters · 2016 · 162 citations
Medicine, Cancer Biology, Oncology +12